Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-019345
Filing Date
2022-02-10
Accepted
2022-02-10 16:08:31
Documents
1
Period of Report
2021-12-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225887-1_5seq1.html 5  
1 OWNERSHIP DOCUMENT tm225887-1_5seq1.xml 5 7201
  Complete submission text file 0001104659-22-019345.txt   8717
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Komjathy Andrew (Reporting) CIK: 0001788465 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37467 | Film No.: 22613967